ACELRX PHARMACEUTICALS INC's ticker is ACRX and the CUSIP is 00444T100. A total of 60 filers reported holding ACELRX PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $407,000 | -13.6% | 1,947,140 | +1.0% | 0.00% | – |
| Q2 2022 | $471,000 | -25.6% | 1,927,154 | -13.1% | 0.00% | – |
| Q1 2022 | $633,000 | -49.2% | 2,218,010 | -0.3% | 0.00% | – |
| Q4 2021 | $1,246,000 | -45.5% | 2,223,875 | -0.7% | 0.00% | – |
| Q3 2021 | $2,286,000 | -26.9% | 2,240,185 | -1.1% | 0.00% | – |
| Q2 2021 | $3,128,000 | -75.8% | 2,266,040 | -70.2% | 0.00% | – |
| Q1 2021 | $12,945,000 | +85.1% | 7,614,345 | +35.0% | 0.00% | – |
| Q4 2020 | $6,995,000 | -9.7% | 5,640,946 | +3.4% | 0.00% | – |
| Q3 2020 | $7,746,000 | +16.2% | 5,455,022 | -1.0% | 0.00% | – |
| Q2 2020 | $6,666,000 | -0.2% | 5,509,735 | -2.7% | 0.00% | – |
| Q1 2020 | $6,678,000 | -43.6% | 5,659,788 | +0.9% | 0.00% | – |
| Q4 2019 | $11,841,000 | -13.8% | 5,612,017 | -10.1% | 0.00% | -100.0% |
| Q3 2019 | $13,732,000 | -10.3% | 6,241,579 | +3.2% | 0.00% | 0.0% |
| Q2 2019 | $15,301,000 | +81.6% | 6,047,743 | +149.8% | 0.00% | – |
| Q1 2019 | $8,427,000 | +56.5% | 2,421,257 | +3.8% | 0.00% | – |
| Q4 2018 | $5,386,000 | +78.0% | 2,331,736 | +196.6% | 0.00% | – |
| Q3 2018 | $3,026,000 | +33.2% | 786,034 | +16.8% | 0.00% | – |
| Q2 2018 | $2,271,000 | +65.0% | 673,115 | +2.7% | 0.00% | – |
| Q1 2018 | $1,376,000 | +5.0% | 655,378 | +1.2% | 0.00% | – |
| Q4 2017 | $1,310,000 | -55.7% | 647,467 | +0.8% | 0.00% | – |
| Q3 2017 | $2,955,000 | +111.4% | 642,380 | -1.2% | 0.00% | – |
| Q2 2017 | $1,398,000 | -79.7% | 650,347 | -70.2% | 0.00% | – |
| Q1 2017 | $6,882,000 | +229300.0% | 2,184,626 | +166284.3% | 0.00% | – |
| Q4 2016 | $3,000 | -40.0% | 1,313 | 0.0% | 0.00% | – |
| Q3 2016 | $5,000 | +25.0% | 1,313 | 0.0% | 0.00% | – |
| Q2 2016 | $4,000 | -93.8% | 1,313 | -92.2% | 0.00% | – |
| Q4 2015 | $65,000 | +3150.0% | 16,787 | +2819.5% | 0.00% | – |
| Q1 2015 | $2,000 | -50.0% | 575 | 0.0% | 0.00% | – |
| Q4 2014 | $4,000 | +33.3% | 575 | 0.0% | 0.00% | – |
| Q3 2014 | $3,000 | -50.0% | 575 | 0.0% | 0.00% | – |
| Q2 2014 | $6,000 | -33.3% | 575 | -20.2% | 0.00% | – |
| Q1 2014 | $9,000 | +28.6% | 721 | +20.8% | 0.00% | – |
| Q4 2013 | $7,000 | +16.7% | 597 | 0.0% | 0.00% | – |
| Q3 2013 | $6,000 | 0.0% | 597 | 0.0% | 0.00% | – |
| Q2 2013 | $6,000 | – | 597 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Perceptive Advisors | 3,731,342 | $8,022,000 | 0.40% |
| WealthTrust Axiom LLC | 210,000 | $451,000 | 0.17% |
| Palo Alto Investors LP | 1,032,715 | $2,220,000 | 0.10% |
| ELEMENT CAPITAL MANAGEMENT LLC | 144,536 | $311,000 | 0.06% |
| SHEPHERD KAPLAN KROCHUK, LLC | 49,761 | $107,000 | 0.06% |
| Joel Isaacson & Co., LLC | 70,660 | $152,000 | 0.03% |
| LMR Partners LLP | 148,309 | $319,000 | 0.02% |
| LINCOLN CAPITAL CORP | 10,000 | $22,000 | 0.02% |
| Malaga Cove Capital, LLC | 13,150 | $28,000 | 0.02% |
| Cornerstone Capital, Inc. | 30,000 | $65,000 | 0.01% |